Rate My Professor Angela Bruzzaniti

Dr. Bruzzaniti's federally funded research program centers on cellular mechanisms underlying bone remodeling, with a focus on preventing bone loss and promoting bone growth. Her scholarly interests encompass cell biology, bone biology, and skeletal physiology, as reflected in her Google Scholar profile with over 2,500 citations. Notable publications include 'The Rho-GEF Kalirin regulates bone mass and the function of osteocytes and osteoclasts' (Bone, 2013), 'Pyk2 and Megakaryocytes Regulate Osteoblast Differentiation and Matrix Mineralization' (Journal of Cellular Biochemistry, 2015), 'Osteocyte-Derived CaMKK2 Regulates Osteoclasts and Bone Mass' (International Journal of Molecular Sciences, 2023), 'High Bone Mass in Mice Lacking Cx37 Because of Defective Osteoclastogenesis' (Journal of Biological Chemistry, 2005), and 'Reversal of Bone Loss in Mice by Nongenotropic Signaling of Parathyroid Hormone' (Science, 2002). She contributes to major NIH initiatives, including a Practice-Based Research Integrating Multidisciplinary Experiences in Dental, Oral, and Craniofacial Research (PRIMED) grant and projects representing one of the largest awards in the dental school's history. Through her leadership in PhD training and student research, Dr. Bruzzaniti fosters the next generation of oral health researchers and faculty.